Ϫ1 ⅐ min Ϫ1 ) and to slow volume expansion (saline 35 ml/kg for 90 min) alone and in combination were investigated in separate experiments. L-Arginine left blood pressure and plasma ANG II unaffected but decreased heart rate (6 Ϯ 2 beats/min) and urine osmolality, increased glomerular filtration rate (GFR) transiently, and caused sustained increases in sodium excretion (fourfold) and urine flow (0.2 Ϯ 0.0 to 0.7 Ϯ 0.1 ml/min). Volume expansion increased arterial blood pressure (102 Ϯ 3 to 114 Ϯ 3 mmHg), elevated GFR persistently by 24%, and enhanced sodium excretion to a peak of 251 Ϯ 31 mol/min, together with marked increases in urine flow, osmolar and free water clearances, whereas plasma ANG II decreased (8.1 Ϯ 1.7 to 1.6 Ϯ 0.3 pg/ml). Combined volume expansion and L-arginine infusion tended to increase arterial blood pressure and increased GFR by 31%, whereas peak sodium excretion was enhanced to 335 Ϯ 23 mol/min at plasma ANG II levels of 3.0 Ϯ 1.1 pg/ml; urine flow and osmolar clearance were increased at constant free water clearance. In conclusion, L-arginine 1) increases sodium excretion, 2) decreases basal urine osmolality, 3) exaggerates the natriuretic response to volume expansion by an average of 50% without persistent changes in GFR, and 4) abolishes the increase in free water clearance normally occurring during volume expansion. Thus L-arginine is a natriuretic substance compatible with a role of nitric oxide in sodium homeostasis, possibly by offsetting/shifting the renal response to sodium excess. sodium excretion; free water clearance; angiotensin PHYSICAL, NEURAL, AND HUMORAL mechanisms are involved in the control of renal sodium excretion. However, the relative influence of each of the components is still controversial, and the evaluation of the importance of the renin-angiotensin system vs. the role of nitric oxide (NO) in renal sodium homeostasis is particularly complex. The natriuretic effect of volume expansion is linked to a decrease in plasma levels of ANG II (e.g., 2, 5), and an intact NO synthesis is also a prerequisite for volume expansion natriuresis (e.g., 3). However, the relative importance and possible interaction between the two systems are poorly elucidated.NO is a potent renal vasodilator and natriuretic substance synthesized in the kidney (14,15,27,31,33,36). It has been shown that acute and chronic elevations in extracellular fluid volume lead to increased NO synthesis (9,16,26,29). Conversion of L-arginine into the vasorelaxant NO takes place in endothelial cells in response to a variety of stimuli by the enzyme NO synthase (NOS). In a recent study in dogs (3), we blocked the NOS unspecifically using the structural analog N G -nitro-L-arginine methyl ester (L-NAME) and demonstrated that this NOS inhibition is followed by increases in plasma ANG II, renal hypofiltration, and severe antinatriuresis that may be no more than returned to control levels by a sizeable volume expansion (3.5% body wt). Thus NOS inhibition virtually abolishes the volume expansion natriuresis, and thi...